- Home
- BUSE vs KNSA Comparison
BUSE vs KNSA Comparison
Compare BUSE & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- KNSA
- Stock Information
- Founded
- BUSE 1868
- KNSA 2015
- Country
- BUSE United States
- KNSA United Kingdom
- Employees
- BUSE N/A
- KNSA N/A
- Industry
- BUSE Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- KNSA Health Care
- Exchange
- BUSE Nasdaq
- KNSA Nasdaq
- Market Cap
- BUSE 1.4B
- KNSA 1.5B
- IPO Year
- BUSE N/A
- KNSA 2018
- Fundamental
- Price
- BUSE $20.82
- KNSA $20.79
- Analyst Decision
- BUSE Buy
- KNSA Strong Buy
- Analyst Count
- BUSE 5
- KNSA 6
- Target Price
- BUSE $27.80
- KNSA $37.17
- AVG Volume (30 Days)
- BUSE 720.4K
- KNSA 661.6K
- Earning Date
- BUSE 04-22-2025
- KNSA 05-06-2025
- Dividend Yield
- BUSE 4.72%
- KNSA N/A
- EPS Growth
- BUSE N/A
- KNSA N/A
- EPS
- BUSE 1.98
- KNSA N/A
- Revenue
- BUSE $453,703,000.00
- KNSA $423,239,000.00
- Revenue This Year
- BUSE $65.20
- KNSA $37.21
- Revenue Next Year
- BUSE $12.01
- KNSA $2.58
- P/E Ratio
- BUSE $10.71
- KNSA N/A
- Revenue Growth
- BUSE 3.25
- KNSA 56.60
- 52 Week Low
- BUSE $18.40
- KNSA $17.04
- 52 Week High
- BUSE $28.97
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- BUSE 49.67
- KNSA 50.01
- Support Level
- BUSE $19.55
- KNSA $19.62
- Resistance Level
- BUSE $21.76
- KNSA $20.89
- Average True Range (ATR)
- BUSE 0.90
- KNSA 1.17
- MACD
- BUSE 0.22
- KNSA -0.02
- Stochastic Oscillator
- BUSE 71.73
- KNSA 74.36
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.